Actively Recruiting
Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial
Led by The First Affiliated Hospital of Guangzhou Medical University · Updated on 2025-03-27
400
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
Sponsors
T
The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor
T
Third Medical Center of Chinese PLA General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This multicenter, randomized, controlled superiority trial (the SCULPT trial) aims to compare the efficacy and safety of a novel steerable flexible and navigable suction ureteral access sheath (FANS) versus the conventional FANS in the treatment of lower pole renal stones ≤2 cm. Lower pole stones are particularly challenging due to the narrow infundibular-pelvic anatomy that limits the maneuverability of standard FANS. The steerable FANS incorporates an active deflection mechanism that allows for independent control, potentially improving the success rate of accessing the lower pole calyx, performing laser lithotripsy, and aspirating stone fragments without additional adjuncts. A total of 400 patients from 20 high-volume urological centers in China (approximately 20 patients per center) will be randomized in a 1:1 ratio to receive either steerable FANS or conventional FANS during flexible ureteroscopy. Primary outcome measures include the success rate of FANS navigation into the lower pole calyx as evidenced by direct stone visualization, effective laser lithotripsy, and successful stone aspiration. Secondary outcomes will assess immediate and 1-month stone-free rates, operative time, complication rates, instrument durability, and improvements in quality of life. This study is expected to provide critical evidence to guide clinical decision-making and potentially improve treatment efficiency for challenging lower pole renal stones.
CONDITIONS
Official Title
Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18-75 years
- Diagnosed with a single lower pole renal stone 2 cm or smaller by CT
- American Society of Anesthesiology (ASA) score of 1-3
- Able to provide written informed consent
- Willing and able to comply with trial procedures and follow-up
You will not qualify if you...
- Urinary tract anatomical abnormalities such as horseshoe kidney or ileal conduit
- Untreated urinary tract infection
- Multiple stones or stones located outside the lower pole
- Absolute contraindications to flexible ureteroscopy
- Unable to understand or complete trial documentation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Urology, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510230
Actively Recruiting
Research Team
G
Guohua Zeng, M.D.
CONTACT
S
Steffi Yuen, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here